600201.SH
生物股份
SSE · Healthcare · Biotechnology · CN
CNY 12.43
−1.74%Forward multiples
Based on analyst estimates
- P/E forward
- 32.37x
- P/E 2026E
- 55.14x
- P/E 2027E
- 40.99x
- P/E 2028E
- 35.14x
- P/S forward
- 6.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- 136.57x
- PEG TTM
- 0.43x
- Price / book
- 2.55x
- Price / sales
- 9.72x
- Price / cash flow
- 44.90x
Enterprise value
- Enterprise value
- CNY 12.4B
- EV / sales
- 8.91x
- EV / EBITDA
- 34.08x
- EV / EBIT
- 116.66x
- Market cap
- CNY 13.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026